Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.51 USD +3.07 (+1.14%)
Streaming Delayed Price Updated: 9:30 AM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Stocks Hitting 52-Week Lows
HollyFrontier Corp (NYSE: HFC) shares dropped 1.98 percent to touch a new 52-week low of $23.74. HollyFrontier shares ... 
Tags 52 Week Lows Benzinga Movers & Shakers
From Benzinga
3 Biotech Stocks to Buy Now: CELG, REGN and BIIB
 
Tags NASDAQ:BIIB NASDAQ:REGN NASDAQ:CELG
From InvestorPlace
Biotech stocks are in for more election trouble on drug pricing
Hillary Clinton and Donald Trump have vowed to take action, writes Michael Brush. 
Tags Personal Finance INCY Health/Care
From MarketWatch
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the ... 
Tags BIIB Juno Therapeutics vertex pharmaceuticals
From Benzinga
Biotech Rally Fizzles As Global Healthcare Issues Weigh…Update-1
The strong biotech rally fizzled early this week as longer term healthcare issues weighed on investors. High expectations from breakthrough products were tempered by the lingering long term concerns of... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
5 Biotech Takeover Targets That Could Get Bought Soon
Don’t let the resurgence in M&A in the biotech sector pass you by. Bret Jensen shares his top five picks for likely acquisition targets in biotech. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
5 Attractive Biotechnology Stocks For Healthy Long-term Returns
The biotechnology sector contains many exciting growth stocks.Consequently, I offer the following 5 biotechnology stocks as attractive looking research candidates primarily for growth or long-term... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
4 Stocks That Crushed the Biotechnology ETF This Week
Although biotech has been a strong area of the market for quite some time, the past year has been a brutal stretch for this segment. 
Tags ETF's Healthcare Stocks / Equities
From Blogs - TalkMarkets
Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD
 
Tags NYSE:BMY NYSE:ABBV NYSE:AZN
From InvestorPlace
The Daily Shot And Data - June 8, 2016
The Eurozone GDP was revised up amid improved household spending. Will this be the year the euro area's economy grows faster than the US? 
Tags Currencies/Forex Basic Materials / Commodities Energy
From Blogs - TalkMarkets
Lingo Failure Leads Citi To Downgrade Biogen
Biogen Inc (NASDAQ: BIIB) announced that anti-Lingo failed both the primary and the secondary endpoints in its Phase 2 RRMS ... 
Tags Health Care Downgrades Benzinga
From Benzinga
Dow Jones Industrial Average Finishes Day Just Shy Of 18,000
The S&P 500 flirted with a new record high as traders cheered the rally in crude oil prices and the removal of a key line in a Janet Yellen speech about the timing of the next interest rate hike. 
Tags Basic Materials / Commodities Consumer Goods Healthcare
From Blogs - TalkMarkets
Why Biogen Inc (BIIB), LendingClub Corp (LC) and Valeant Pharmaceuticals Intl Inc (VRX) Are Three of Today’s Worst Stocks
 
Tags NASDAQ:BIIB NYSE:LC Stock Market Today
From InvestorPlace
Where Is Biotech Going From Here?
The weakness in biotech is keeping the Nasdaq from experiencing a rally of any sorts today, despite the Dow, SPX, Rut all on solid ground. Where does that leave biotech going forward? 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Markets advance at midday
The markets advanced during the midday with the Dow climbing 74 points to 17,994 as crude oil prices edged up. Nasdaq rose 9 points to 4,978. 
Tags Market News
From MarketMinute.com Market Updates
Mid-Afternoon Market Update: Navistar Climbs Following Earnings Beat; Biogen Shares Tumble
Toward the end of trading Tuesday, the Dow traded up 0.45 percent to 18,000.08 while the NASDAQ climbed 0.15 percent to 4,975.90. ... 
Tags EAC Markets Construction & Farm Machinery & Heavy Trucks
From Benzinga
Biogen Inc: BIIB Loses $8B on Drug Failure, But Upside Remains
 
Tags NASDAQ:BIIB Stocks to Buy
From InvestorPlace
Tuesday's ETF Movers: XOP, IBB
In trading on Tuesday, the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is outperforming other ETFs, up about 2.5% on the day. Components of that ETF showing particular strength include shares... 
Tags ETFs
From ETF Channel
8 Biggest Mid-Day Losers For Tuesday
DryShips Inc. (NASDAQ: DRYS) shares fell 44.07 percent to $1.32 after the company announced that it has breached some financial ... 
Tags Movers & Shakers MIK Benzinga
From Benzinga
Mid-Day Market Update: LDR Rises On Acquisition News; DryShips Shares Drop
Midway through trading Tuesday, the Dow traded up 0.44 percent to 18,000.01 while the NASDAQ climbed 0.08 percent to 4,972.72. The ... 
Tags PACD Commodities AREX
From Benzinga
IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy
 
Tags NASDAQ:AMGN NASDAQ:BIIB NASDAQ:ALXN
From InvestorPlace
Biogen Blitzed, Hits Lowest Level Since March
Biogen Inc (NASDAQ: BIIB) shares are trading lower by $37 (12 percent) at $252.84 in Tuesday's session. The catalyst for the ... 
Tags Benzinga Trading Ideas BIIB
From Benzinga
Noteworthy Tuesday Option Activity: CYTR, BIIB, Z
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CytRx Corp (CYTR), where a total volume of 14,664 contracts has been traded thus... 
Tags Stocks
From Market News Video
Hottest Manufacturing Stocks Now – AEHR SRPT NAV AXLL
 
Tags NYSE:AXLL NYSE:CTLT NYSE:RL
From InvestorPlace
Biogen Plunges After MS Treatment Misses Primary, Secondary Endpoints In Study
The SYNERGY Phase 2 study evaluated opicinumab among 418 patients with relapsing forms of MS over 72 weeks. Results are expected to be presented at future medical meetings, the company said. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Shares of Biogen Idec Are Down on Strong Volume (BIIB)
The price of Biogen Idec shares has slipped to $257.70 (a 11.1% change) on heavy trading volume. Today's volume of 3.3 million shares tops the average 30-day volume of... 
From Comtex SmarTrend® News Briefs
Nasdaq 100 Movers: BIIB, WDC
In early trading on Tuesday, shares of Western Digital (WDC) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.2%. Year to date, Western Digital has lost... 
Tags Stocks
From Market News Video
S&P 500 Movers: BIIB, WDC
In early trading on Tuesday, shares of Western Digital (WDC) topped the list of the day's best performing components of the S&P 500 index, trading up 3.4%. Year to date, Western Digital has lost about... 
Tags Stocks
From Market News Video
Mid-Morning Market Update: Markets Mostly Higher; Valeant Earnings Miss Views
Following the market opening Tuesday, the Dow traded up 0.35 percent to 17,982.82 while the NASDAQ climbed 0.03 percent to 4,970.14. ... 
Tags Mid/Morning Market Update Markets DRYS
From Benzinga
12 Stocks Moving In Tuesday's Pre-Market Session
Gainers LDR Holding Corp (NASDAQ: LDRH) rose 62.31 percent to $36.65 in pre-market trading as the company agreed to be ... 
Tags RGLS BIIB HMNY
From Benzinga
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.